Over and over there are reports about the increasing rise of antibiotic-resistant bugs. Even as the number of resistant bacteria increases, the number of companies developing new types of antibiotics is decreasing. Earlier this year, a coalition of healthcare organizations,…
Equipping Small Sites to Manage Trial Finances: Challenges and Solutions
A sponsor chooses a site based on its ability to conduct the research, not on its financial management skills. But poor money management can sink a trial regardless of how well the site conducts the research. In today’s budget-conscious environment,…
Does joining a clinical trial make you a guinea pig?
Clinical trials are carefully designed and monitored for research studies to test drugs, devices or procedures to find out if they are safe and effective before they can be approved for marketing and general public use. Without a clinical…
Siro Clinpharm undergoes a brand refresh
Siro Clinpharm has announced a refresh of its core brand elements. Reflecting the growth and evolution of Siro as India’s leading CRO (Clinical research organisation), the brand elevates the focus on dependability, progressiveness, being scientific, and best in industry. This…
Paying for Trial Participation: A Question of Incentive v. Influence
When it comes to offering to pay clinical trial subjects to participate, the line between compensation and coercion is difficult to draw but all too easy to cross. Reimbursing participants for expenses incurred — travel, lodging, childcare — is…
Packaging Trends and the Future of the Generics Market in India
Around the world, the pharmaceutical market is rapidly evolving, driven by greater access to medicines, an increased focus on patient needs and the emergence of innovative therapies for chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis. Industry analyst…
Novotech CRO strengthens South Korean Clinical Capabilities partnering with 2 Major Hospitals
Ulsan University Hospital (UHH) and Seoul National University Hospital (SNUH), Hepatology Division have joined the Novotech CRO partnership program SYDNEY, Apr 18, 2019 – (ACN Newswire) – Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region,…
Development of biologics: The market requires short development times and high productivity
Biologics offer new therapy options for numerous diseases: They are already used to treat cancer and autoimmune diseases such as rheumatoid arthritis as useful alternatives to standard therapies. The extent of their market potential is revealed by the fact…
Pharm-Olam Wins 2019 CRO Leadership Awards
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, has been named a winner in Life Science Leader magazine’s 2019 CRO Leadership Awards. Pharm-Olam was rated highly by…
Top Academic Centers Flouting Trial Reporting Requirements, Report Shows
Top U.S. academic centers are routinely ignoring federal rules requiring them to report clinical trial data, a new analysis by a pair of nonprofit advocacy groups finds. Nearly one-third of the 450 university-based trials surveyed by Universities Allied for Essential…
